Ament, SJ; Maus, S; Reber, H et al.
PET lung ventilation/perfusion imaging using (68)Ga aerosol (Galligas) and (68)Ga-labeled macroaggregated albuminRecent Results Cancer Res. Bd. 194. 2013 S. 395-423
Schulz, Eberhard; Kroeller-Schoen, Swenja; Jansen, Thomas et al.
PGC-1 alpha deletion accelerates angiotensin II induced endothelial dysfunction by increasing mitochondrial oxidative stress and vascular agingFASEB JOURNAL. Bd. 27. 2013
Holthoewer, D.; Kirschbaum, K. M.; Frisch, J. et al.
Pharmacodynamic Effects of Aripiprazole and Ziprasidone with Respect to P-Glycoprotein Substrate PropertiesPHARMACOPSYCHIATRY. Bd. 46. H. 5. 2013 S. 175-180
Olson, S.; Baron, K.; Riggs, M. et al.
PHARMACOKINETIC MODELLING OF THE RELATIONSHIP BETWEEN SUSTAINED VIROLOGICAL RESPONSE AND PLASMA CONCENTRATIONS OF FALDAPREVIR OR BI-207127 IN HCV GT1-INFECTED PATIENTS IN SOUND-C2JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S492-S493
Krause, Petra; Fuhr, Uwe; Schnitker, Joerg et al.
Pharmacokinetics of Intravesical Versus Oral Oxybutynin in Healthy Adults: Results of an Open Label, Randomized, Prospective Clinical StudyJOURNAL OF UROLOGY. Bd. 190. H. 5. 2013 S. 1791-1797
Hofmann, Daniel; Mailaender, Volker
Pharmacology of nanocarriers on the microscale: importance of uptake mechanisms and intracellular trafficking for efficient drug deliveryNANOMEDICINE. Bd. 8. H. 3. 2013 S. 321-323
Franke, A; Lieb, K
Pharmakologisches "Cognitive Enhancement"Hessisches Ärzteblatt. H. 2. 2013 S. 87-90
Dreimüller, N; Lieb, K; Tadic, A
Pharmakotherapie der therapieresistenten DepressionFreitag CM, Barocka A, Fehr C, Grube M, Hampel H (Hrsg). Depressive Störungen über die Lebensspanne. 1. Aufl. Stuttgart: Kohlhammer 2013
de Dosso, S.; Fiedler, W.; Gianni, L. et al.
PHASE I CLINICAL AND PHARMACOLOGICAL STUDY OF CETUGEX, A NOVEL ANTI-EGFR MONOCLONAL ANTIBODY WITH AN OPTIMIZED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITYANNALS OF ONCOLOGY. Bd. 24. 2013 S. 8-8
Hoehler, T.; von Wichert, G.; Schimanski, C. et al.
Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205BRITISH JOURNAL OF CANCER. Bd. 109. H. 6. 2013 S. 1408-1413